POSIMIR

Peak

bupivacaine

NDAINFILTRATIONSOLUTION
Approved
Feb 2021
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
19

Clinical Trials (5)

NCT05575999Phase 1Not Yet Recruiting

Effectiveness of Bupivacaine, Ketorolac, Ketamine, vs Bupivacaine Alone in Reducing Postoperative Pocket Pain

Started Jan 2026
200 enrolled
Pain Management
NCT06252662Phase 4Recruiting

Liposomal Bupivacaine Vs Bupivacaine with Dexmedetomidine in Erector Spinae Plane Blocks for Mastectomies

Started Oct 2024
200 enrolled
Breast Cancer
NCT05409820N/ACompleted

Comparative Analysis of Hypobaric Versus Hyperbaric Bupivacaine for Spinal Anesthesia in Day-Case Anorectal Surgery

Started Feb 2022
NCT04394533Phase 4Recruiting

Hyperbaric Prilocaine Compared With Hyperbaric Bupivacaine in Cervical Cerclage?

Started Aug 2021
135 enrolled
Cervical Incompetence in Pregnancy as Antepartum Condition
NCT04033562Phase 4Terminated

The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis

Started Jan 2020

Loss of Exclusivity

LOE Date
Jan 12, 2041
180 months away
Patent Expiry
Jan 12, 2041

Patent Records (2)

Patent #ExpiryTypeUse Code
11400019
Jan 12, 2041
Product
11771624
Jan 12, 2041
U-3724